MK-677 (Ibutamoren) Reconstitution Calculator

The calculator is a dilution tool that can be used for any dry powder. However, MK‑677 is formulated for oral administration and is not intended for injection. Its pharmacokinetics, bioavailability, and safety in an injectable form have not been established for research. Published data describe it exclusively as an oral compound for research. If you use the calculator to dissolve MK‑677 powder and then inject it, you would be administering the compound via a non‑validated route. The calculator’s output will be mathematically correct, but it cannot warn you about the potential for unexpected toxicity, altered absorption, or local tissue damage from the injection.

Some sources list the solubility of Ibutamoren mesylate in water as being over 50 mg/mL. While the calculator assumes the powder will simply dissolve, the fact that the compound is hygroscopic means it readily absorbs moisture from the air. This can lead to clumping, making it harder to dissolve accurately. If your powder has caked together before you use it, the calculator’s volume will be based on an ideal powder, not the sticky, clumped material you have. To get accurate results, ensure your powder is stored desiccated and at room temperature before use.

You must first convert the mg/kg dose into a total mg amount for the subject. For example, a study on dogs used a dose of 5 mg/kg/day. For a 10 kg animal, that is 50 mg total. You can enter this 50 mg into the calculator’s Desired dose field. But you will also need to decide on a vehicle. For an oral liquid suspension, you will need to calculate the desired concentration (e.g., 50 mg / 0.5 mL = 100 mg/mL) and then use that to determine how much powder and solvent to combine. The calculator’s “Doses per vial” display is not directly relevant here, as a single vial may contain enough powder for many animals.

The calculator assumes the solution remains fully potent for the duration of your use. For MK‑677, one source states that after reconstitution in a solvent, the solution should be stored at -20 °C and used within 1 to 3 months to prevent loss of potency. It also notes that you should aliquot the solution to avoid multiple freeze/thaw cycles. Therefore, the calculator’s “Doses per vial” count is only a guide. For a long-term study, you could prepare a single concentrated stock, freeze it, and draw doses as needed, but the calculator cannot help you calculate the number of doses after multiple freeze‑thaw cycles or tell you how quickly the solution will degrade.

The calculator only displays a concentration and volume. It does not account for non‑linear pharmacokinetics. In clinical research, the most common dose is 25 mg/day. A dose comparison study found that increasing the dose from 10 mg to 25 mg produced a 17% increase in bone turnover markers, but doses above 25 mg have been shown to have a significant diminishing return. If you use the calculator to prepare a 50 mg or 100 mg dose, you would not get proportionally more GH release. The calculator’s output is mathematically correct, but the biological effect will plateau. For accurate research, you should not simply scale up the mass; you must determine the optimum dose from the literature.